EBI3 and nasopharyngeal carcinoma: EBI3 was associated with several human malignancies and detected in EBV-associated tumors, nasopharyngeal carcinoma (NPC), and Hodgkin lymphoma (HL) to inhibit an effective antitumor, independently of its association to IL-27p28 [21, 22].